Michael B. Jebsen
2011
In 2011, Michael B. Jebsen earned a total compensation of $332.3K as President, Interim Chief Executive and Chief Financial Officer at Tenax Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $70,000 |
|---|---|
| Option Awards | $42,720 |
| Salary | $210,000 |
| Other | $9,600 |
| Total | $332,320 |
Jebsen received $210K in salary, accounting for 63% of the total pay in 2011.
Jebsen also received $70K in non-equity incentive plan, $42.7K in option awards and $9.6K in other compensation.
Rankings
In 2011, Michael B. Jebsen's compensation ranked 9,166th out of 10,747 executives tracked by ExecPay. In other words, Jebsen earned more than 14.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,166 out of 10,747 | 15th |
Division Manufacturing | 3,411 out of 3,960 | 14th |
Major group Chemicals And Allied Products | 871 out of 1,038 | 16th |
Industry group Drugs | 648 out of 786 | 18th |
Industry Pharmaceutical Preparations | 484 out of 571 | 15th |
Source: SEC filing on September 6, 2011.
Jebsen's colleagues
We found three more compensation records of executives who worked with Michael B. Jebsen at Tenax Therapeutics in 2011.